Hesitation waltz at the Paris Bourse. The CAC 40, which opened in the green in the wake of Wall Street erases most of its gains to move around equilibrium midterm, just above the 4,000 points, he found the day before. The index symbolically Paris advance of 0.01% to 4001 points.

The trend is also vague on other major European markets. In Frankfurt, the Dax as grapppille ACC 0.01% at 6157.7 points Monday after reaching its highest level since September 2008 while in London the FTSE slips 0.09% at 5705.5 points.

The figures in France

INSEE released at 8:45 the detailed national accounts for the fourth quarter. The GDP grew Hexagon as previously estimated 0.6% in the fourth quarter. On the year, growth fell by 2.2%.

Household consumption grew by 1% over the last three months of 2009.Purchasing power has slowed (+0.2% against +0.5% in the third quarter), but rose by INSEE of 2.1% throughout the year.

Moreover, the number of starts of new homes in France fell 12.8% during the months from December 2009 to February 2010 compared to the same period a year ago, and the number of building permits has folded by 14.3%, said Tuesday the Department of Ecology.

Across the Atlantic, all eyes will be on the S & P / Case-Shiller housing price, to be published 15 hours. An hour later, consumer confidence will be unveiled in March.At 18:30, the economic advisor to President Barack Obama, Paul Volcker, will speak at the Peterson Institute.

But the main highlight of the week on the macroeconomic level is expected Friday with the release of monthly statistics of unemployment in the United States.

The Multaq Sanofi recommended in the United Kingdom

EDF (+1.69% at 55.77 euros) is leading the largest increases of ACC 40.Merrill Lynch raised its price target to 47 euros, against 45.4 previously, and reiterated its buy advice, believing that the future law on opening the electricity market should "significantly improve the visibility" on the active French EDF payday loans online.

Sanofi-Aventis (0.50% to 41.25 euros) announced Tuesday that the National Institute for Health and Clinical Excellence (NICE) has released a new report evaluating the medicine of the future, the Multaq in which the Institute expressed its intention to recommend the use of this drug for the treatment of patients with atrial fibrillation. The drug for heart disease from Sanofi-Aventis had been considered "poor" by the Commission on transparency in France, which had sealed the title of the pharmaceutical company.

The TGV Tours-Bordeaux Vinci

On Tuesday, investors have taken note of the happy elect of the draft Tours-Bordeaux TGV. Vinci (+1.45% at 44.11 euros) won the tender for the contract by more than 7 billion euros against Eiffage and Bouygues.

Wendel (-2.83% to 44.91 euros) announced a net loss of 809 million euros in 2009.The net asset value has doubled since 2008 and stood at 56.9 euros per share.

Vranken Pommery, it said net income Group share up 7.8%. The group spiritueuxversera Champagne and a dividend of 1.15 euro. The title wins 2.50%, to 30.75 euros.

Pre-market Transdev, whose merger with Veolia Transport should be completed in the second half of 2010 will hold a press conference presenting the results and balance sheet activity in 2009. Veolia wins 0.44% to 26.11 euros.

On Tuesday, will also be held a hearing at the Commercial Court of Paris on Natixis (+0.20% to 4.02 euro).Minority shareholders, united behind the consultancy Deminor have assigned the bank in early January for "spreading false, misleading or deceptive on the prospects for Natixis in its creation.

After Hours, the annual results 2009 Neopost (balance) will be published.

tags, , , ,

Comments are closed.